Cargando…

Molecular Mechanisms of Cerebrovascular Diseases

Detalles Bibliográficos
Autores principales:	Andjelkovic, Anuska V., Keep, Richard F., Wang, Michael M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266541/ https://www.ncbi.nlm.nih.gov/pubmed/35806164 http://dx.doi.org/10.3390/ijms23137161

Ejemplares similares

Modeling blood–brain barrier pathology in cerebrovascular disease in vitro: current and future paradigms
por: Andjelkovic, Anuska V., et al.
Publicado: (2020)

Expression of periaxin (PRX) specifically in the human cerebrovascular system: PDZ domain-mediated strengthening of endothelial barrier function
por: Wang, Michael M., et al.
Publicado: (2018)

Brain Endothelial Cell-Cell Junctions: How to “Open” the Blood Brain Barrier
por: Stamatovic, Svetlana M, et al.
Publicado: (2008)

Epigenetics and stroke: role of DNA methylation and effect of aging on blood-brain barrier recovery
por: Phillips, Chelsea, et al.
Publicado: (2023)

Involvement of Epigenetic Mechanisms and Non-coding RNAs in Blood-Brain Barrier and Neurovascular Unit Injury and Recovery After Stroke
por: Stamatovic, Svetlana M., et al.
Publicado: (2019)

Cerebral Cavernous Malformation Pathogenesis: Investigating Lesion Formation and Progression with Animal Models
por: Phillips, Chelsea M., et al.
Publicado: (2022)

Epigenetics and stroke: role of DNA methylation and effect of aging on blood–brain barrier recovery
por: Phillips, Chelsea M., et al.
Publicado: (2023)

Vascular disruption and blood–brain barrier dysfunction in intracerebral hemorrhage
por: Keep, Richard F, et al.
Publicado: (2014)

Transcriptomic Profile of Blood–Brain Barrier Remodeling in Cerebral Amyloid Angiopathy
por: Situ, Muyu, et al.
Publicado: (2022)

New Insights into Antithrombotic Therapy for Cardio- and Cerebrovascular Disease: From Molecular Mechanisms to Clinical Application
por: Cirillo, Plinio, et al.
Publicado: (2023)

Cerebrovascular Disorders
por: Granata, Alessandra, et al.
Publicado: (2023)

mTOR in cerebrovascular disease
por: Van Skike, Candice E., et al.
Publicado: (2019)

Natural Antioxidant in Cardiovascular and Cerebrovascular Diseases
por: Jung, Yi-Sook
Publicado: (2022)

Cerebrovascular Diseases: Perspectives for the Next Decade
por: Corea, Francesco
Publicado: (2010)

Behavioural and Cognitive Effects of Cerebrovascular Diseases
por: Owolabi, Mayowa, et al.
Publicado: (2018)

Visualization of Chemokine Binding Sites on Human Brain Microvessels
por: Andjelkovic, Anuska V., et al.
Publicado: (1999)

Vitamin D and Cerebrovascular Disease
por: Christopher, Rita, et al.
Publicado: (2021)

Lipid Metabolism and Signaling in Tumors and Cerebrovascular Diseases
por: Gatti, Laura
Publicado: (2022)

Novel Drugs Development for Cardio-/Cerebrovascular Diseases
por: Sheu, Joen-Rong, et al.
Publicado: (2014)

The Current State of Cell Therapies for Cerebrovascular Diseases
por: Jolkkonen, Jukka, et al.
Publicado: (2016)

Cerebrovascular dysfunction links aging to neurological disease
por: Van Skike, Candice E., et al.
Publicado: (2020)

Aging diabetes, deconstructing the cerebrovascular wall
por: Fan, Fan, et al.
Publicado: (2021)

Editorial for the Molecular Genetics and Genomics of Metabolic Disorders in Cardiovascular and Cerebrovascular Diseases Special Issue: June 2023
por: Zhao, Yuanyuan, et al.
Publicado: (2023)

Consensus, the College and Cerebrovascular Medicine
por: Bamford, J M
Publicado: (1995)

Cerebrovascular Disorders: Role of Aging
por: Popa-Wagner, Aurel, et al.
Publicado: (2012)

Cerebrovascular Regulation in Neurological Disorders
por: Yang, Yi, et al.
Publicado: (2018)

Bioactives and Traditional Herbal Medicine for the Treatment of Cardiovascular/Cerebrovascular Diseases
por: Sheu, Joen-Rong, et al.
Publicado: (2014)

IL-12– and IL-23–modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition
por: Kroenke, Mark A., et al.
Publicado: (2008)

Editorial: New Advances in Cerebrovascular Disorders
por: Karapanayiotides, Theodoros, et al.
Publicado: (2023)

Changes in the Association between Blood Pressure Indices and Subclinical Cerebrovascular Diseases
por: Satoh, Michihiro
Publicado: (2022)

Bioactives and Traditional Herbal Medicine for the Treatment of Cardiovascular/Cerebrovascular Diseases 2015
por: Sheu, Joen-Rong, et al.
Publicado: (2015)

Retirement of Dr. Hazel Jones as Co-Editor-in-Chief of Fluids and Barriers of the CNS. Dr. Mark Hamilton becomes Co-Editor-in-Chief
por: Keep, Richard F., et al.
Publicado: (2023)

Cross-over endocytosis of claudins is mediated by interactions via their extracellular loops
por: Gehne, Nora, et al.
Publicado: (2017)

Residual recurrence risk of ischaemic cerebrovascular events: concept, classification and implications
por: Wang, Yongjun
Publicado: (2021)

Cell and Molecular Mechanics in Health and Disease
por: Kawauchi, Keiko, et al.
Publicado: (2017)

Advances in brain barriers and brain fluids research in 2021: great progress in a time of adversity
por: Keep, Richard F., et al.
Publicado: (2022)

News from the editors of Fluids and Barriers of the CNS
por: Drewes, Lester R, et al.
Publicado: (2014)

Advances in brain barriers and brain fluid research and news from Fluids and Barriers of the CNS
por: Drewes, Lester R., et al.
Publicado: (2016)

Brain barriers and brain fluid research in 2016: advances, challenges and controversies
por: Keep, Richard F., et al.
Publicado: (2017)

Progress in brain barriers and brain fluid research in 2017
por: Keep, Richard F., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0k1ba78f8735ha7qf8bimeknfk